Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter S N van Rossum

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
International Journal of Colorectal Disease|June 1, 2016
Letter to the Editor on the article "The role of low CRP values in the prediction of the development of acute diverticulitis"Aristotelis Kechagias, Peter S N van Rossum
The Lancet. Gastroenterology & Hepatology|September 21, 2023
CROSS versus modified MAGIC or FLOT in oesophageal and gastro-oesophageal junction adenocarcinomaPeter S N van Rossum, Hanneke W M van Laarhoven
The Lancet. Oncology|March 29, 2023
Adding PD-1 inhibition to chemoradiotherapy for oesophageal cancerHanneke W M van Laarhoven, Peter S N van Rossum
Annals of Surgical Oncology|March 21, 2022
ASO Author Reflections: Role of Local Treatment for Oligometastatic Esophagogastric CancerTiuri E Kroese, Peter S N van Rossum, Richard van Hillegersberg
JAMA Oncology|April 23, 2026
Rethinking Treatment Intent Beyond the Curative/Palliative Binary in Modern OncologyHanneke W M van Laarhoven, Inge Henselmans, Peter S N van Rossum
Frontiers in Oncology|July 17, 2024
Editorial: Updates on radiation-induced lymphopeniaPim J J Damen, Steven H Lin, Peter S N van Rossum
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|January 28, 2026
Neoadjuvant or perioperative treatment in resectable esophageal adenocarcinoma beyond ESOPEC: tailoring FLOT or CROSSPeter S N van Rossum, Hanneke W M van Laarhoven, Richard van Hillegersberg
European Journal of Cancer (Oxford, England : 1990)|July 19, 2015
Comment on: Hölscher AH, Bollschweiler E, Bogoevski D, Schmidt H, Semrau R, Izbicki JR. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer – A propensity score matched analysis. Eur J Cancer. 2014;50(17):2950-7Peter S N van Rossum, Lucas Goense, Richard van Hillegersberg, et al.
The Annals of Thoracic Surgery|February 10, 2016
Ischemic Conditioning of the Stomach in the Prevention of Esophagogastric Anastomotic Leakage After EsophagectomyAristotelis Kechagias, Peter S N van Rossum, Jelle P Ruurda, et al.
Annals of Surgery|July 26, 2017
Impact of Lymph Node Yield on Overall Survival in Patients Treated With Neoadjuvant Chemoradiotherapy Followed by Esophagectomy for Cancer: A Population-based Cohort Study in the NetherlandsEls Visser, Peter S N van Rossum, Jelle P Ruurda, et al.
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
International Journal of Colorectal Disease|June 1, 2016
Letter to the Editor on the article "The role of low CRP values in the prediction of the development of acute diverticulitis"Aristotelis Kechagias, Peter S N van Rossum
The Lancet. Gastroenterology & Hepatology|September 21, 2023
CROSS versus modified MAGIC or FLOT in oesophageal and gastro-oesophageal junction adenocarcinomaPeter S N van Rossum, Hanneke W M van Laarhoven
The Lancet. Oncology|March 29, 2023
Adding PD-1 inhibition to chemoradiotherapy for oesophageal cancerHanneke W M van Laarhoven, Peter S N van Rossum
Annals of Surgical Oncology|March 21, 2022
ASO Author Reflections: Role of Local Treatment for Oligometastatic Esophagogastric CancerTiuri E Kroese, Peter S N van Rossum, Richard van Hillegersberg
JAMA Oncology|April 23, 2026
Rethinking Treatment Intent Beyond the Curative/Palliative Binary in Modern OncologyHanneke W M van Laarhoven, Inge Henselmans, Peter S N van Rossum
Frontiers in Oncology|July 17, 2024
Editorial: Updates on radiation-induced lymphopeniaPim J J Damen, Steven H Lin, Peter S N van Rossum
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|January 28, 2026
Neoadjuvant or perioperative treatment in resectable esophageal adenocarcinoma beyond ESOPEC: tailoring FLOT or CROSSPeter S N van Rossum, Hanneke W M van Laarhoven, Richard van Hillegersberg
European Journal of Cancer (Oxford, England : 1990)|July 19, 2015
Comment on: Hölscher AH, Bollschweiler E, Bogoevski D, Schmidt H, Semrau R, Izbicki JR. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer – A propensity score matched analysis. Eur J Cancer. 2014;50(17):2950-7Peter S N van Rossum, Lucas Goense, Richard van Hillegersberg, et al.
The Annals of Thoracic Surgery|February 10, 2016
Ischemic Conditioning of the Stomach in the Prevention of Esophagogastric Anastomotic Leakage After EsophagectomyAristotelis Kechagias, Peter S N van Rossum, Jelle P Ruurda, et al.
Annals of Surgery|July 26, 2017
Impact of Lymph Node Yield on Overall Survival in Patients Treated With Neoadjuvant Chemoradiotherapy Followed by Esophagectomy for Cancer: A Population-based Cohort Study in the NetherlandsEls Visser, Peter S N van Rossum, Jelle P Ruurda, et al.
Pageof 13